Filing Details
- Accession Number:
- 0001127602-11-006365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-18 12:00:00
- Reporting Period:
- 2011-02-17
- Filing Date:
- 2011-02-18
- Accepted Time:
- 2011-02-18 15:09:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504983 | E. Robert Gagnon | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Chief Acct Officer Vp & Contr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-17 | 732 | $67.10 | 10,537 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $67.01 (low) and 67.23 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
Billionaire Hedge Funds
